Clinical trials: Myasthaenia Gravis

Myasthaenia Gravis

The Evaluation of Belimumab in Myasthenia Gravis (MG)

• Completed
• Age: 18 years and older
• Phase 2
• Results posted

Study BEL115123 is a randomized, placebo-controlled, double-blind, multinational study of belimumab (10 mg/kg) to investigate the efficacy and safety of belimumab in subjects with MG.

Trial name

NCT01480596

Testing

Belimumab

Where

25 sites in United States, Canada and 2 more

Volunteers

40 people

Sponsor

GlaxoSmithKline